

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.97566241 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.86288113 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.86288113 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.86288113 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.86288113 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.86288113 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.86288113 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.51411185 |
| 9 | microglial cell activation (GO:0001774) | 5.39599518 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.28177887 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.08944601 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.74727330 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.71392791 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.71392791 |
| 15 | polyketide metabolic process (GO:0030638) | 4.56578995 |
| 16 | doxorubicin metabolic process (GO:0044598) | 4.56578995 |
| 17 | daunorubicin metabolic process (GO:0044597) | 4.56578995 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.37951356 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 4.34874360 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26664348 |
| 21 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.20599647 |
| 22 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.18185250 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 4.17663106 |
| 24 | response to host (GO:0075136) | 4.08971305 |
| 25 | response to host defenses (GO:0052200) | 4.08971305 |
| 26 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.08971305 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 4.06632246 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 3.98397379 |
| 29 | macrophage activation (GO:0042116) | 3.94016436 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.88797617 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.85411524 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 3.80432206 |
| 33 | cellular response to interferon-beta (GO:0035458) | 3.77772180 |
| 34 | response to host immune response (GO:0052572) | 3.70865942 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.70865942 |
| 36 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.69616781 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.65391118 |
| 38 | semaphorin-plexin signaling pathway (GO:0071526) | 3.56661571 |
| 39 | positive regulation of histone deacetylation (GO:0031065) | 3.50811275 |
| 40 | purinergic receptor signaling pathway (GO:0035587) | 3.46558043 |
| 41 | response to peptidoglycan (GO:0032494) | 3.45623306 |
| 42 | T cell migration (GO:0072678) | 3.39902272 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 3.37439063 |
| 44 | response to interferon-beta (GO:0035456) | 3.34745556 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33735572 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.32870395 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.31235921 |
| 48 | response to type I interferon (GO:0034340) | 3.27470243 |
| 49 | regulation of ARF GTPase activity (GO:0032312) | 3.27337892 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.27313212 |
| 51 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.24824986 |
| 52 | cellular response to type I interferon (GO:0071357) | 3.21656595 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.21656595 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.19157440 |
| 55 | negative regulation of norepinephrine secretion (GO:0010700) | 3.17168126 |
| 56 | cellular response to exogenous dsRNA (GO:0071360) | 3.16282300 |
| 57 | mast cell activation (GO:0045576) | 3.13544086 |
| 58 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.12789500 |
| 59 | cellular response to zinc ion (GO:0071294) | 3.12607282 |
| 60 | regulation of extracellular matrix disassembly (GO:0010715) | 3.11134678 |
| 61 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10673667 |
| 62 | I-kappaB phosphorylation (GO:0007252) | 3.08894520 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.08488399 |
| 64 | negative regulation of stress fiber assembly (GO:0051497) | 3.07014437 |
| 65 | germinal center formation (GO:0002467) | 3.05203713 |
| 66 | endothelial cell chemotaxis (GO:0035767) | 3.03790820 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.02860717 |
| 68 | thymic T cell selection (GO:0045061) | 3.02376698 |
| 69 | pinocytosis (GO:0006907) | 3.01887100 |
| 70 | negative regulation of cell size (GO:0045792) | 3.01385451 |
| 71 | nucleoside diphosphate catabolic process (GO:0009134) | 3.01326729 |
| 72 | regulation of B cell differentiation (GO:0045577) | 2.99936501 |
| 73 | T-helper 1 type immune response (GO:0042088) | 2.96791471 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96363024 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95764177 |
| 76 | respiratory burst (GO:0045730) | 2.94161106 |
| 77 | cellular extravasation (GO:0045123) | 2.93228586 |
| 78 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.92775872 |
| 79 | glycosphingolipid catabolic process (GO:0046479) | 2.91597119 |
| 80 | positive regulation of interferon-beta production (GO:0032728) | 2.90394438 |
| 81 | immunoglobulin mediated immune response (GO:0016064) | 2.86702605 |
| 82 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.85121100 |
| 83 | myeloid leukocyte activation (GO:0002274) | 2.84774900 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84258349 |
| 85 | response to muramyl dipeptide (GO:0032495) | 2.81777885 |
| 86 | defense response to protozoan (GO:0042832) | 2.81112906 |
| 87 | negative regulation of cell killing (GO:0031342) | 2.80848582 |
| 88 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80848582 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79929732 |
| 90 | necroptotic process (GO:0070266) | 2.79560216 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 2.78490050 |
| 92 | positive regulation of protein deacetylation (GO:0090312) | 2.78163829 |
| 93 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.78093729 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.77861775 |
| 95 | megakaryocyte development (GO:0035855) | 2.76034771 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.75305978 |
| 97 | negative regulation of granulocyte differentiation (GO:0030853) | 2.75297265 |
| 98 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.73340597 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 2.72657728 |
| 100 | glycolipid catabolic process (GO:0019377) | 2.71771889 |
| 101 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.71695981 |
| 102 | mast cell activation involved in immune response (GO:0002279) | 2.70732217 |
| 103 | mast cell degranulation (GO:0043303) | 2.70732217 |
| 104 | atrioventricular valve morphogenesis (GO:0003181) | 2.68545893 |
| 105 | regulation of T cell tolerance induction (GO:0002664) | 2.67730156 |
| 106 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67531242 |
| 107 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.66750195 |
| 108 | regulation of RIG-I signaling pathway (GO:0039535) | 2.65887874 |
| 109 | toxin transport (GO:1901998) | 2.65348884 |
| 110 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65309157 |
| 111 | negative regulation of phagocytosis (GO:0050765) | 2.64683873 |
| 112 | histone H3-K4 trimethylation (GO:0080182) | 2.64366037 |
| 113 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.63743224 |
| 114 | myeloid dendritic cell differentiation (GO:0043011) | 2.62780900 |
| 115 | mannose metabolic process (GO:0006013) | 2.62085695 |
| 116 | dendritic cell differentiation (GO:0097028) | 2.62035923 |
| 117 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61728488 |
| 118 | negative regulation of lipid storage (GO:0010888) | 2.60029277 |
| 119 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59655311 |
| 120 | angiogenesis involved in wound healing (GO:0060055) | 2.59420178 |
| 121 | positive regulation of macrophage differentiation (GO:0045651) | 2.58906917 |
| 122 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.58306027 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.56379808 |
| 124 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.56364201 |
| 125 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.56090404 |
| 126 | detection of bacterium (GO:0016045) | 2.54923699 |
| 127 | positive regulation of receptor recycling (GO:0001921) | 2.53646800 |
| 128 | apoptotic process involved in morphogenesis (GO:0060561) | 2.52729451 |
| 129 | T cell selection (GO:0045058) | 2.50016969 |
| 130 | activation of JUN kinase activity (GO:0007257) | 2.48605761 |
| 131 | histone H4 deacetylation (GO:0070933) | 2.48599939 |
| 132 | adhesion of symbiont to host cell (GO:0044650) | 2.45189685 |
| 133 | virion attachment to host cell (GO:0019062) | 2.45189685 |
| 134 | activation of MAPKKK activity (GO:0000185) | 2.44960805 |
| 135 | response to laminar fluid shear stress (GO:0034616) | 2.44576324 |
| 136 | detection of other organism (GO:0098543) | 2.44444828 |
| 137 | activation of Rac GTPase activity (GO:0032863) | 2.42095683 |
| 138 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.40894024 |
| 139 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.38829377 |
| 140 | barbed-end actin filament capping (GO:0051016) | 2.38620359 |
| 141 | protein heterotrimerization (GO:0070208) | 2.36959958 |
| 142 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.35365624 |
| 143 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.34033138 |
| 144 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.33441513 |
| 145 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.33391923 |
| 146 | response to magnesium ion (GO:0032026) | 2.33166115 |
| 147 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.32867582 |
| 148 | regulation of extracellular matrix organization (GO:1903053) | 2.32591736 |
| 149 | histone H3 deacetylation (GO:0070932) | 2.31679322 |
| 150 | adhesion of symbiont to host (GO:0044406) | 2.30846567 |
| 151 | positive regulation of extracellular matrix organization (GO:1903055) | 2.30518049 |
| 152 | stress fiber assembly (GO:0043149) | 2.29267950 |
| 153 | regulation of leukocyte degranulation (GO:0043300) | 2.28457908 |
| 154 | retrograde transport, endosome to Golgi (GO:0042147) | 2.28028649 |
| 155 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.27892415 |
| 156 | regulation of monocyte differentiation (GO:0045655) | 2.27238939 |
| 157 | positive regulation of protein kinase C signaling (GO:0090037) | 2.26382173 |
| 158 | cellular response to virus (GO:0098586) | 2.25482658 |
| 159 | negative regulation of interleukin-8 production (GO:0032717) | 2.24869627 |
| 160 | negative regulation of interleukin-2 production (GO:0032703) | 2.22388870 |
| 161 | negative thymic T cell selection (GO:0045060) | 2.20678843 |
| 162 | response to fluid shear stress (GO:0034405) | 2.20421928 |
| 163 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.19626363 |
| 164 | Rho protein signal transduction (GO:0007266) | 2.18856368 |
| 165 | negative regulation of fatty acid transport (GO:2000192) | 2.18805101 |
| 166 | embryonic process involved in female pregnancy (GO:0060136) | 2.18778671 |
| 167 | response to manganese ion (GO:0010042) | 2.18485730 |
| 168 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.18246019 |
| 169 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.17572066 |
| 170 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.16986721 |
| 171 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.15271901 |
| 172 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.14965687 |
| 173 | regulation of histone H3-K27 methylation (GO:0061085) | 2.14894901 |
| 174 | detection of external biotic stimulus (GO:0098581) | 2.14446996 |
| 175 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.12797424 |
| 176 | positive regulation of cholesterol efflux (GO:0010875) | 2.12385164 |
| 177 | regulation of tumor necrosis factor production (GO:0032680) | 2.11998521 |
| 178 | regulation of ARF protein signal transduction (GO:0032012) | 2.11913411 |
| 179 | regulation of ruffle assembly (GO:1900027) | 2.11719139 |
| 180 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.11673094 |
| 181 | cell-cell junction maintenance (GO:0045217) | 2.10819047 |
| 182 | positive T cell selection (GO:0043368) | 2.10577149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.66579762 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41273297 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.73379512 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.14529254 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.95487928 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.81545289 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.81078092 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72303734 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.64686867 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.59369619 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.58860683 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.58407840 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.23458110 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.12231945 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.96604291 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73677047 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70454466 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.68311161 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65653300 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64514698 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.58594074 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.57260246 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48311463 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.33949542 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.32806614 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28600149 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24424403 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24159006 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.14105526 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13463085 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13345139 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06992807 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06490269 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05806432 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05133177 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93867979 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93746550 |
| 38 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93453683 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.90892222 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.90641322 |
| 41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87375146 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85417731 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84911283 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82594634 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77003739 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75378622 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.74587567 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74348717 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.72684178 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71486844 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.71379336 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70371111 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68386481 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.68073917 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65936100 |
| 56 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.65393920 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60714143 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.60041529 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58577148 |
| 60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57737571 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.57161332 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.56385903 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55762336 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51913394 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50256385 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49364686 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48801110 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48668503 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.47641181 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46951497 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46180543 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.46165173 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45784542 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43050863 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42629473 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42265803 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40946178 |
| 78 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.38392227 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37340861 |
| 80 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37240579 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36970532 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36493682 |
| 83 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.34607622 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34117169 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.31615018 |
| 86 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30844898 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 1.30810073 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29987186 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29520491 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28712791 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27425194 |
| 92 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26159576 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25808887 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24232383 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24157280 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23589355 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23330389 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23034113 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22603445 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20539024 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19877240 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19480555 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18843330 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18594837 |
| 105 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17222787 |
| 106 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17060772 |
| 107 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16288020 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15657046 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15605578 |
| 110 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.15384073 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15102220 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14733521 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12590917 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10788303 |
| 115 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10081082 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08847883 |
| 117 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08758340 |
| 118 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.07570937 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06797612 |
| 120 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06524907 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05476207 |
| 122 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04504707 |
| 123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03713706 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03230186 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02260083 |
| 126 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01660376 |
| 127 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01137902 |
| 128 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00822204 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00384156 |
| 130 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00015260 |
| 131 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99953415 |
| 132 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99923979 |
| 133 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99086148 |
| 134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98161028 |
| 135 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97162300 |
| 136 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94703482 |
| 137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94377020 |
| 138 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92734502 |
| 139 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91731177 |
| 140 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86694655 |
| 141 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86567468 |
| 142 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85190805 |
| 143 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81020497 |
| 144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79156965 |
| 145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78894243 |
| 146 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76425349 |
| 147 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75476176 |
| 148 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73081527 |
| 149 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.72976101 |
| 150 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71485967 |
| 151 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.70184599 |
| 152 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70154925 |
| 153 | MAF_26560356_Chip-Seq_TH2_Human | 0.70075078 |
| 154 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.69743863 |
| 155 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.69134615 |
| 156 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67572740 |
| 157 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66422289 |
| 158 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64686837 |
| 159 | RXR_22108803_ChIP-Seq_LS180_Human | 0.62790616 |
| 160 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.60644125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.03630329 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.26269909 |
| 3 | * MP0005058_abnormal_lysosome_morphology | 3.00500072 |
| 4 | * MP0003172_abnormal_lysosome_physiology | 2.95538341 |
| 5 | * MP0002419_abnormal_innate_immunity | 2.82452043 |
| 6 | MP0003724_increased_susceptibility_to | 2.81512053 |
| 7 | MP0006082_CNS_inflammation | 2.80434505 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.78184162 |
| 9 | MP0000685_abnormal_immune_system | 2.73637229 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.69021441 |
| 11 | MP0005671_abnormal_response_to | 2.67761744 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.66718791 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.66020231 |
| 14 | MP0009840_abnormal_foam_cell | 2.62360162 |
| 15 | MP0009785_altered_susceptibility_to | 2.59144284 |
| 16 | MP0003436_decreased_susceptibility_to | 2.55123943 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.48742968 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.45946206 |
| 19 | * MP0002452_abnormal_antigen_presenting | 2.30881644 |
| 20 | MP0005025_abnormal_response_to | 2.25419315 |
| 21 | MP0001800_abnormal_humoral_immune | 2.23530660 |
| 22 | MP0008260_abnormal_autophagy | 2.16773783 |
| 23 | MP0005387_immune_system_phenotype | 2.15411509 |
| 24 | MP0001790_abnormal_immune_system | 2.15411509 |
| 25 | MP0002723_abnormal_immune_serum | 2.11700433 |
| 26 | MP0003075_altered_response_to | 2.09553092 |
| 27 | MP0003303_peritoneal_inflammation | 2.04318755 |
| 28 | MP0005670_abnormal_white_adipose | 2.02144769 |
| 29 | * MP0002420_abnormal_adaptive_immunity | 2.02069051 |
| 30 | * MP0001819_abnormal_immune_cell | 2.01403978 |
| 31 | * MP0003690_abnormal_glial_cell | 1.93315615 |
| 32 | MP0005503_abnormal_tendon_morphology | 1.91247587 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.88598497 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.86200813 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.83577037 |
| 36 | MP0005451_abnormal_body_composition | 1.81661398 |
| 37 | MP0000343_altered_response_to | 1.78287482 |
| 38 | MP0001873_stomach_inflammation | 1.73893550 |
| 39 | MP0004510_myositis | 1.69307748 |
| 40 | MP0001853_heart_inflammation | 1.67098289 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.66878235 |
| 42 | MP0002405_respiratory_system_inflammati | 1.66370846 |
| 43 | MP0005360_urolithiasis | 1.61124673 |
| 44 | MP0003279_aneurysm | 1.60728751 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.58151012 |
| 46 | MP0002398_abnormal_bone_marrow | 1.55172945 |
| 47 | MP0003091_abnormal_cell_migration | 1.53899723 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.53864706 |
| 49 | * MP0000716_abnormal_immune_system | 1.53496203 |
| 50 | MP0003828_pulmonary_edema | 1.51523627 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.49367169 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.49218126 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.46163492 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.42870259 |
| 55 | MP0005310_abnormal_salivary_gland | 1.42775344 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.39550501 |
| 57 | MP0004858_abnormal_nervous_system | 1.38907187 |
| 58 | * MP0008469_abnormal_protein_level | 1.38805089 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.38530713 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.36742539 |
| 61 | MP0003646_muscle_fatigue | 1.36562865 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.34845189 |
| 63 | MP0000013_abnormal_adipose_tissue | 1.33160897 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.31785557 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.31715959 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.31653398 |
| 67 | MP0005023_abnormal_wound_healing | 1.30188865 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.29621086 |
| 69 | * MP0002429_abnormal_blood_cell | 1.29114861 |
| 70 | MP0009764_decreased_sensitivity_to | 1.28989650 |
| 71 | MP0002722_abnormal_immune_system | 1.27895544 |
| 72 | MP0000751_myopathy | 1.27045225 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.26429060 |
| 74 | MP0001542_abnormal_bone_strength | 1.22488045 |
| 75 | MP0000003_abnormal_adipose_tissue | 1.22443610 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.22089241 |
| 77 | MP0004381_abnormal_hair_follicle | 1.22010214 |
| 78 | MP0005275_abnormal_skin_tensile | 1.17287480 |
| 79 | MP0005166_decreased_susceptibility_to | 1.17011450 |
| 80 | * MP0001849_ear_inflammation | 1.15551647 |
| 81 | MP0004883_abnormal_blood_vessel | 1.15031472 |
| 82 | MP0002060_abnormal_skin_morphology | 1.14429307 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 1.13497751 |
| 84 | MP0005257_abnormal_intraocular_pressure | 1.12653924 |
| 85 | MP0002254_reproductive_system_inflammat | 1.12149678 |
| 86 | MP0005409_darkened_coat_color | 1.10424625 |
| 87 | MP0004130_abnormal_muscle_cell | 1.08974107 |
| 88 | MP0004947_skin_inflammation | 1.08417028 |
| 89 | MP0005646_abnormal_pituitary_gland | 1.07892332 |
| 90 | MP0009278_abnormal_bone_marrow | 1.07492472 |
| 91 | MP0000249_abnormal_blood_vessel | 1.04885746 |
| 92 | MP0000678_abnormal_parathyroid_gland | 1.04426829 |
| 93 | MP0003045_fibrosis | 1.03218741 |
| 94 | MP0006054_spinal_hemorrhage | 1.02413172 |
| 95 | MP0002933_joint_inflammation | 1.01733027 |
| 96 | MP0002006_tumorigenesis | 1.00530639 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.99686606 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.98723543 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.97557286 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.97557286 |
| 101 | MP0005164_abnormal_response_to | 0.96984059 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.93797290 |
| 103 | MP0005390_skeleton_phenotype | 0.93501580 |
| 104 | MP0010368_abnormal_lymphatic_system | 0.92644267 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.92042602 |
| 106 | MP0005508_abnormal_skeleton_morphology | 0.91397215 |
| 107 | MP0000604_amyloidosis | 0.89598730 |
| 108 | MP0003866_abnormal_defecation | 0.89323530 |
| 109 | MP0003329_amyloid_beta_deposits | 0.89071946 |
| 110 | * MP0003795_abnormal_bone_structure | 0.86157470 |
| 111 | MP0003448_altered_tumor_morphology | 0.86135157 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.84230283 |
| 113 | MP0001243_abnormal_dermal_layer | 0.83782262 |
| 114 | MP0000371_diluted_coat_color | 0.83564007 |
| 115 | MP0005377_hearing/vestibular/ear_phenot | 0.83190118 |
| 116 | MP0003878_abnormal_ear_physiology | 0.83190118 |
| 117 | MP0000490_abnormal_crypts_of | 0.82649574 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.81223377 |
| 119 | MP0000703_abnormal_thymus_morphology | 0.80972474 |
| 120 | MP0001958_emphysema | 0.80461186 |
| 121 | MP0001851_eye_inflammation | 0.79259965 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.78897874 |
| 123 | MP0003879_abnormal_hair_cell | 0.78891969 |
| 124 | MP0009115_abnormal_fat_cell | 0.76595393 |
| 125 | MP0008874_decreased_physiological_sensi | 0.75010729 |
| 126 | MP0005165_increased_susceptibility_to | 0.74863274 |
| 127 | MP0001663_abnormal_digestive_system | 0.74585737 |
| 128 | MP0002796_impaired_skin_barrier | 0.74450793 |
| 129 | MP0002095_abnormal_skin_pigmentation | 0.73594565 |
| 130 | MP0000858_altered_metastatic_potential | 0.70743770 |
| 131 | MP0004782_abnormal_surfactant_physiolog | 0.69710806 |
| 132 | MP0002090_abnormal_vision | 0.69397394 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.68185108 |
| 134 | MP0003186_abnormal_redox_activity | 0.66719514 |
| 135 | * MP0000767_abnormal_smooth_muscle | 0.65681112 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.65476135 |
| 137 | MP0002132_abnormal_respiratory_system | 0.65027975 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.63499692 |
| 139 | MP0009763_increased_sensitivity_to | 0.60768700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.51880015 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.86138349 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.82833277 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.65573671 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.65573671 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.65573671 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.25234334 |
| 8 | Myositis (HP:0100614) | 4.24469177 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.11319226 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.98884266 |
| 11 | Protrusio acetabuli (HP:0003179) | 3.85082555 |
| 12 | Spondylolisthesis (HP:0003302) | 3.81059003 |
| 13 | Orchitis (HP:0100796) | 3.65730689 |
| 14 | * Dysostosis multiplex (HP:0000943) | 3.64651524 |
| 15 | Recurrent skin infections (HP:0001581) | 3.58357477 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.51253716 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.50691828 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.47614669 |
| 19 | Thin bony cortex (HP:0002753) | 3.46199907 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.45652661 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.44893334 |
| 22 | Impaired platelet aggregation (HP:0003540) | 3.44704447 |
| 23 | Abnormal platelet function (HP:0011869) | 3.44704447 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.44499953 |
| 25 | Optic neuritis (HP:0100653) | 3.42913210 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.42913210 |
| 27 | Petechiae (HP:0000967) | 3.30495647 |
| 28 | Nuclear cataract (HP:0100018) | 3.30040487 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28305700 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28305700 |
| 31 | Stridor (HP:0010307) | 3.27543199 |
| 32 | Premature rupture of membranes (HP:0001788) | 3.27462039 |
| 33 | Recurrent viral infections (HP:0004429) | 3.23155718 |
| 34 | Epistaxis (HP:0000421) | 3.21501215 |
| 35 | Inflammation of the large intestine (HP:0002037) | 3.07527382 |
| 36 | Chronic otitis media (HP:0000389) | 3.01729151 |
| 37 | Arterial thrombosis (HP:0004420) | 3.01051253 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.00564789 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97712325 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.88875040 |
| 41 | Albinism (HP:0001022) | 2.87340289 |
| 42 | Depressed nasal tip (HP:0000437) | 2.87073310 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.82329018 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.78529118 |
| 45 | Basal ganglia calcification (HP:0002135) | 2.76398834 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.75197300 |
| 47 | Distal upper limb amyotrophy (HP:0007149) | 2.75197300 |
| 48 | * Joint stiffness (HP:0001387) | 2.73295330 |
| 49 | Axonal loss (HP:0003447) | 2.72514941 |
| 50 | Thrombocytosis (HP:0001894) | 2.64199177 |
| 51 | Colitis (HP:0002583) | 2.63643462 |
| 52 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.62532222 |
| 53 | * Abnormality of polysaccharide metabolism (HP:0011012) | 2.62532222 |
| 54 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.62532222 |
| 55 | Vertebral compression fractures (HP:0002953) | 2.61362929 |
| 56 | Chronic diarrhea (HP:0002028) | 2.60797377 |
| 57 | Emphysema (HP:0002097) | 2.60208668 |
| 58 | * Obstructive sleep apnea (HP:0002870) | 2.57981560 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.57437329 |
| 60 | Gingivitis (HP:0000230) | 2.57367069 |
| 61 | Atrophic scars (HP:0001075) | 2.56350552 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.56148214 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.53629151 |
| 64 | Periodontitis (HP:0000704) | 2.53525644 |
| 65 | Arterial tortuosity (HP:0005116) | 2.52579244 |
| 66 | Increased connective tissue (HP:0009025) | 2.51106021 |
| 67 | Fragile skin (HP:0001030) | 2.50725648 |
| 68 | Gingival bleeding (HP:0000225) | 2.46563674 |
| 69 | Meningitis (HP:0001287) | 2.45687146 |
| 70 | Lymphangioma (HP:0100764) | 2.43572755 |
| 71 | Aneurysm (HP:0002617) | 2.41924887 |
| 72 | Shallow orbits (HP:0000586) | 2.41716215 |
| 73 | Vascular tortuosity (HP:0004948) | 2.41224989 |
| 74 | Broad metatarsal (HP:0001783) | 2.40889694 |
| 75 | Thoracic kyphosis (HP:0002942) | 2.38669201 |
| 76 | * Mucopolysacchariduria (HP:0008155) | 2.38656860 |
| 77 | * Urinary glycosaminoglycan excretion (HP:0003541) | 2.38656860 |
| 78 | Dilatation of the ascending aorta (HP:0005111) | 2.35766857 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.35382496 |
| 80 | Bruising susceptibility (HP:0000978) | 2.34261917 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.33642887 |
| 82 | Cellulitis (HP:0100658) | 2.32280327 |
| 83 | Urticaria (HP:0001025) | 2.31299344 |
| 84 | Hyperacusis (HP:0010780) | 2.29644135 |
| 85 | Vasculitis (HP:0002633) | 2.28989102 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 2.28530779 |
| 87 | Increased IgE level (HP:0003212) | 2.28133576 |
| 88 | Fatigue (HP:0012378) | 2.26266798 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25672037 |
| 90 | Obstructive lung disease (HP:0006536) | 2.25672037 |
| 91 | Pustule (HP:0200039) | 2.24617637 |
| 92 | Asymmetric septal hypertrophy (HP:0001670) | 2.22371702 |
| 93 | Joint hemorrhage (HP:0005261) | 2.21075496 |
| 94 | Blue sclerae (HP:0000592) | 2.20895992 |
| 95 | Abnormality of the lumbar spine (HP:0100712) | 2.17915617 |
| 96 | Keratoconjunctivitis sicca (HP:0001097) | 2.17705209 |
| 97 | Glomerulonephritis (HP:0000099) | 2.15978516 |
| 98 | Abnormality of the columella (HP:0009929) | 2.15151584 |
| 99 | * Broad face (HP:0000283) | 2.14937149 |
| 100 | Chest pain (HP:0100749) | 2.14705548 |
| 101 | Cheilitis (HP:0100825) | 2.12184661 |
| 102 | Aortic dissection (HP:0002647) | 2.11311800 |
| 103 | Gastrointestinal stroma tumor (HP:0100723) | 2.10183044 |
| 104 | * Cervical subluxation (HP:0003308) | 2.09202737 |
| 105 | * Hepatosplenomegaly (HP:0001433) | 2.07990345 |
| 106 | IgM deficiency (HP:0002850) | 2.06863460 |
| 107 | Achilles tendon contracture (HP:0001771) | 2.06366001 |
| 108 | Distal lower limb muscle weakness (HP:0009053) | 2.05692670 |
| 109 | Loss of speech (HP:0002371) | 2.03829100 |
| 110 | Agammaglobulinemia (HP:0004432) | 2.01823170 |
| 111 | Hypertriglyceridemia (HP:0002155) | 2.00826763 |
| 112 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00492566 |
| 113 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00492566 |
| 114 | Abnormal protein glycosylation (HP:0012346) | 2.00492566 |
| 115 | Abnormal glycosylation (HP:0012345) | 2.00492566 |
| 116 | Leukocytosis (HP:0001974) | 1.99968557 |
| 117 | Keratoconjunctivitis (HP:0001096) | 1.99349952 |
| 118 | Easy fatigability (HP:0003388) | 1.97804040 |
| 119 | Tetraparesis (HP:0002273) | 1.97355992 |
| 120 | Bladder diverticulum (HP:0000015) | 1.97056222 |
| 121 | Spontaneous hematomas (HP:0007420) | 1.95862755 |
| 122 | * Progressive neurologic deterioration (HP:0002344) | 1.95679207 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.94552867 |
| 124 | Osteomyelitis (HP:0002754) | 1.94384994 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93444694 |
| 126 | Wormian bones (HP:0002645) | 1.91952008 |
| 127 | Abnormality of the Achilles tendon (HP:0005109) | 1.91785616 |
| 128 | Flat acetabular roof (HP:0003180) | 1.91733910 |
| 129 | * J-shaped sella turcica (HP:0002680) | 1.89616655 |
| 130 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88649133 |
| 131 | Hemoptysis (HP:0002105) | 1.88526004 |
| 132 | Neurofibrillary tangles (HP:0002185) | 1.87022873 |
| 133 | Atelectasis (HP:0100750) | 1.86542209 |
| 134 | Restrictive lung disease (HP:0002091) | 1.86524608 |
| 135 | Abnormality of complement system (HP:0005339) | 1.86091055 |
| 136 | Abnormality of the thoracic spine (HP:0100711) | 1.85948002 |
| 137 | * Aortic regurgitation (HP:0001659) | 1.85427257 |
| 138 | Stomatitis (HP:0010280) | 1.84188990 |
| 139 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84144961 |
| 140 | Premature loss of primary teeth (HP:0006323) | 1.83041171 |
| 141 | * Mitral regurgitation (HP:0001653) | 1.81792098 |
| 142 | Aortic aneurysm (HP:0004942) | 1.80730778 |
| 143 | Supranuclear gaze palsy (HP:0000605) | 1.80683870 |
| 144 | Peritonitis (HP:0002586) | 1.80109874 |
| 145 | Recurrent pneumonia (HP:0006532) | 1.79926749 |
| 146 | Panhypogammaglobulinemia (HP:0003139) | 1.79595470 |
| 147 | Malnutrition (HP:0004395) | 1.78724862 |
| 148 | Abnormality of eosinophils (HP:0001879) | 1.78295893 |
| 149 | Retinal atrophy (HP:0001105) | 1.77475128 |
| 150 | Genu recurvatum (HP:0002816) | 1.77438780 |
| 151 | Type I transferrin isoform profile (HP:0003642) | 1.76447675 |
| 152 | Spinal rigidity (HP:0003306) | 1.76258544 |
| 153 | Eosinophilia (HP:0001880) | 1.75937921 |
| 154 | Purpura (HP:0000979) | 1.74840402 |
| 155 | Gastrointestinal infarctions (HP:0005244) | 1.74622035 |
| 156 | Abnormality of lateral ventricle (HP:0030047) | 1.73891609 |
| 157 | Difficulty climbing stairs (HP:0003551) | 1.73562453 |
| 158 | Disproportionate tall stature (HP:0001519) | 1.69821978 |
| 159 | * Biconcave vertebral bodies (HP:0004586) | 1.68162477 |
| 160 | Ulnar bowing (HP:0003031) | 1.67749854 |
| 161 | Long toe (HP:0010511) | 1.67549419 |
| 162 | Joint laxity (HP:0001388) | 1.67021825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.22694608 |
| 2 | MUSK | 4.10250659 |
| 3 | SIK1 | 3.59743691 |
| 4 | KIT | 3.48938864 |
| 5 | MAP4K1 | 2.61925325 |
| 6 | IRAK4 | 2.47089242 |
| 7 | GRK7 | 2.45157385 |
| 8 | TYK2 | 2.39051121 |
| 9 | TNIK | 2.12143853 |
| 10 | ERN1 | 2.11419074 |
| 11 | PRPF4B | 2.09809710 |
| 12 | PIM2 | 2.07481002 |
| 13 | TBK1 | 2.06120959 |
| 14 | CSF1R | 2.05058462 |
| 15 | TAOK3 | 2.04563113 |
| 16 | MAP3K14 | 2.02862673 |
| 17 | STK10 | 2.02281250 |
| 18 | TEC | 1.94040131 |
| 19 | IKBKE | 1.91270370 |
| 20 | RIPK4 | 1.82137042 |
| 21 | JAK3 | 1.79399355 |
| 22 | TXK | 1.77751973 |
| 23 | FLT3 | 1.76857778 |
| 24 | BTK | 1.72744878 |
| 25 | CDK8 | 1.68348949 |
| 26 | IKBKB | 1.67933382 |
| 27 | PRKD2 | 1.67029701 |
| 28 | PKN2 | 1.64171133 |
| 29 | ZAP70 | 1.60579099 |
| 30 | PDGFRA | 1.59031693 |
| 31 | MST1R | 1.50417063 |
| 32 | EPHA2 | 1.48941403 |
| 33 | MAP3K6 | 1.46176384 |
| 34 | MARK2 | 1.45636603 |
| 35 | CDC42BPA | 1.45401587 |
| 36 | SMG1 | 1.43931099 |
| 37 | JAK1 | 1.42965609 |
| 38 | MATK | 1.41905901 |
| 39 | MAP3K3 | 1.40020474 |
| 40 | GRK6 | 1.38631725 |
| 41 | MAP2K6 | 1.35234581 |
| 42 | MOS | 1.34682431 |
| 43 | ICK | 1.29853653 |
| 44 | IRAK3 | 1.28450342 |
| 45 | MAP3K11 | 1.28253757 |
| 46 | TESK1 | 1.24332623 |
| 47 | MAP3K7 | 1.24024223 |
| 48 | BLK | 1.23302144 |
| 49 | SYK | 1.22932856 |
| 50 | TAOK1 | 1.19047244 |
| 51 | TRIB3 | 1.16578117 |
| 52 | NME2 | 1.13783610 |
| 53 | RPS6KA2 | 1.11989994 |
| 54 | DDR2 | 1.08101330 |
| 55 | CAMKK2 | 1.07212918 |
| 56 | PTK6 | 1.07195087 |
| 57 | ARAF | 1.06774482 |
| 58 | CHUK | 1.06099084 |
| 59 | SIK2 | 1.03820185 |
| 60 | FGFR4 | 1.03025756 |
| 61 | LYN | 1.02908806 |
| 62 | MAPK15 | 1.01715122 |
| 63 | PRKD3 | 1.00450284 |
| 64 | HCK | 0.98856282 |
| 65 | BMX | 0.97110153 |
| 66 | LCK | 0.96487931 |
| 67 | TAOK2 | 0.95768919 |
| 68 | HIPK2 | 0.94831636 |
| 69 | FES | 0.94631021 |
| 70 | ITK | 0.93911333 |
| 71 | MAP2K3 | 0.91179953 |
| 72 | TIE1 | 0.91132398 |
| 73 | CLK1 | 0.89938913 |
| 74 | JAK2 | 0.88443505 |
| 75 | BMPR2 | 0.88120539 |
| 76 | PTK2 | 0.87403747 |
| 77 | RIPK1 | 0.86137204 |
| 78 | EEF2K | 0.85098793 |
| 79 | MAPKAPK5 | 0.82889025 |
| 80 | NTRK1 | 0.82151979 |
| 81 | STK38 | 0.81786819 |
| 82 | MAP3K13 | 0.81658515 |
| 83 | PDGFRB | 0.80998549 |
| 84 | GRK5 | 0.79734404 |
| 85 | PIM1 | 0.79225573 |
| 86 | CAMKK1 | 0.78828534 |
| 87 | TRPM7 | 0.77220120 |
| 88 | MTOR | 0.77202040 |
| 89 | PAK4 | 0.76575587 |
| 90 | MAPK7 | 0.74625512 |
| 91 | PDPK1 | 0.73716775 |
| 92 | MAP3K1 | 0.73582620 |
| 93 | DMPK | 0.72918464 |
| 94 | PIK3CG | 0.72058476 |
| 95 | SIK3 | 0.71534842 |
| 96 | RPS6KA6 | 0.71350459 |
| 97 | EIF2AK2 | 0.69748341 |
| 98 | MET | 0.68169976 |
| 99 | TTN | 0.68166830 |
| 100 | CAMK1D | 0.67331667 |
| 101 | NLK | 0.67046531 |
| 102 | CDK9 | 0.65402284 |
| 103 | MARK3 | 0.62615197 |
| 104 | CSK | 0.61892639 |
| 105 | PHKG1 | 0.61844427 |
| 106 | PHKG2 | 0.61844427 |
| 107 | MAPK12 | 0.61787994 |
| 108 | RPS6KC1 | 0.61281455 |
| 109 | RPS6KL1 | 0.61281455 |
| 110 | CDK3 | 0.60543731 |
| 111 | PRKCD | 0.59192126 |
| 112 | FGFR3 | 0.55528005 |
| 113 | DYRK1B | 0.55459291 |
| 114 | PRKD1 | 0.54256402 |
| 115 | IRAK2 | 0.54080171 |
| 116 | MAP3K10 | 0.52982787 |
| 117 | INSRR | 0.52812563 |
| 118 | IGF1R | 0.51590428 |
| 119 | MYLK | 0.51444515 |
| 120 | CDK12 | 0.50980832 |
| 121 | CAMK1 | 0.49532669 |
| 122 | EPHB1 | 0.48894401 |
| 123 | TESK2 | 0.48807407 |
| 124 | PIK3CA | 0.48188059 |
| 125 | MAP2K2 | 0.47396005 |
| 126 | ERBB2 | 0.46121002 |
| 127 | MKNK2 | 0.45891578 |
| 128 | PRKAA2 | 0.45883586 |
| 129 | CAMK4 | 0.45308176 |
| 130 | MAPK4 | 0.45298904 |
| 131 | CASK | 0.45149326 |
| 132 | PRKG2 | 0.44572592 |
| 133 | PDK1 | 0.43517516 |
| 134 | LRRK2 | 0.43113649 |
| 135 | TYRO3 | 0.41658027 |
| 136 | FYN | 0.41191100 |
| 137 | YES1 | 0.41113027 |
| 138 | RPS6KA4 | 0.41067541 |
| 139 | RET | 0.40965138 |
| 140 | MKNK1 | 0.40394774 |
| 141 | MAPKAPK2 | 0.40177342 |
| 142 | ABL1 | 0.38554947 |
| 143 | CDK4 | 0.38547345 |
| 144 | RPS6KA5 | 0.37442692 |
| 145 | PTK2B | 0.37409112 |
| 146 | MAPK11 | 0.37321531 |
| 147 | EPHA3 | 0.36961658 |
| 148 | TNK2 | 0.34971196 |
| 149 | LMTK2 | 0.34510960 |
| 150 | KDR | 0.33209113 |
| 151 | BRSK2 | 0.32770464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.74462102 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22917718 |
| 3 | * Lysosome_Homo sapiens_hsa04142 | 2.77088834 |
| 4 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.71185858 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.65256295 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64522113 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.49485974 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39919039 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.29294077 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26477468 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25852492 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.06444834 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99887120 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99617486 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.89766912 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.82764932 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.77460168 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77024426 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72077236 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68844854 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.68751147 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.55247889 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.53827805 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50477243 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.49565209 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48279264 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45857770 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.45046202 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.44207240 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43502003 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.38510925 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30872228 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30349467 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29985793 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28759288 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.23530941 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20834620 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12070142 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11728220 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11698156 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.08916326 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08733367 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.08353545 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07444145 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.03500466 |
| 46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02411332 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.02308888 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.01943273 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 1.01846974 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.01163642 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00430414 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.99547617 |
| 53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96863243 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96354934 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96157048 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96067336 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95873536 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94245567 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.93748492 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.91904441 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89633171 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.89150094 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89068474 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.88002176 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87598396 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87301306 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.85479964 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85030271 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84234830 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82297952 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81454126 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80799518 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.80453175 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79949881 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79202418 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78020294 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77021579 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76196780 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73160183 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71738818 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.71680765 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70495205 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70362722 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69486268 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69367848 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67286598 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66476220 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66355739 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.65433387 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64554556 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63835105 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63650344 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63329389 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62670441 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62519423 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61809036 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60459661 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59908917 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59490134 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58809989 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58198840 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56821107 |
| 103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55191465 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53898193 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53874521 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53686058 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52015824 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50754246 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49902716 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45712572 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45255356 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45138021 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44577649 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42387039 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.40701770 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39422401 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38778779 |
| 118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35448315 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35228050 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33820332 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33675536 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33416777 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30651911 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27427433 |
| 125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26943572 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26685150 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25786500 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25283670 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25189433 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24563663 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23892215 |

